Selected News from Today's FirstWord

Sanofi, Regeneron's dupilumab cuts asthma exacerbations by 87 percent in mid-stage trial

Sanofi and Regeneron Pharmaceuticals announced Tuesday mid-stage data presented at the American Thoracic Society meeting and published in the NEJM showing that the experimental drug dupilumab cut the Full story

Also in the News

FirstWord Dossier Reports
www.fwreports.com

**NEW** The complete list of FirstWord Dossier reports can be found at www.fwreports.com

FirstWord Dossier reports provide insight, analysis and the latest thinking on important trends and the most challenging issues affecting the pharmaceutical industry today. Highly-focused, relevant, up-to-date and actionable intelligence ... reports that deliver information vital for competitive advantage.

Click here to see our recent reports.

Most Read Stories in the Past Week

Recent Reports